Arterial events, such as strokes, transient ischemic attacks, and myocardial infarctions, tend to predominate due to platelet-driven mechanisms, whereas venous thrombosis, including DVT and pulmonary embolism, though less frequent, carries significant morbidity and is more often observed in JAK2-positive individuals. This evidence concerns the gene JAK2 and myocardial infarction.